-
Professor Zhu Jianwei's team from Shanghai Jiaotong University discovered broad-spectrum neutralizing antibodies against SARS-CoV-2
Time of Update: 2022-03-04
After the outbreak of the new crown epidemic, the team of Professor Zhu Jianwei of the Engineering Research Center for Cell Engineering and Antibody Drugs of the Ministry of Education cooperated with many domestic and foreign enterprises and institutions to clone and screen the B cells of recovered patients to obtain a number of SARS-CoV-2 viruses.
-
Tao Shengce's team published an inactivated vaccine against Omicron mutants...
Time of Update: 2022-03-04
Based on the protein chip platform built in the laboratory, Tao Shengce's team from the Institute of Systems Biomedicine, Shanghai Jiao Tong University used the chip to detect the RBD-specific antibody titer in the serum after inoculation with inactivated vaccine (BBIBP-CorV), and drew the first inoculation.
-
Keixing Announces Breakthrough Therapy Designation for aficamten in China
Time of Update: 2022-03-04
Based on the results of REDWOOD-HCM and the Phase 1 clinical study in China, the National Medical Products Administration granted breakthrough therapy designation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy .
-
New progress in ancient hybridization events and genome-wide doubling of the Camellia family where Kunming plants are located
Time of Update: 2022-03-04
Through analysis, 610 orthologous low-copy nuclear genes (858606 bp) were finally used to construct the phylogenetic framework of Camellia, and the differentiation time, reticular evolution and genome-wide doubling event (WGD) within the family were also discussed.
-
Novel immunosuppressive mechanism of Lin28B on lung-promoting metastatic "niche" in breast cancer
Time of Update: 2022-03-04
On February 16, 2022, the international academic journal Nature Communications published online a report titled "Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer by Zhan Lixing's research group from Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences.
-
Chinese scholars and overseas collaborators have made progress in research on the causes of asymmetric distribution of materials on the front and back of the moon
Time of Update: 2022-03-04
The thermal anomaly generated by the largest impact event (the formation event of the South Pole-Aitken Basin on the back of the moon) promotes the asymmetric distribution of the material composition on the front and back of the moon through the process of mantle overturning, which provides new ideas for the study of the early evolution process of the moon and other terrestrial planets .
-
Nature: Large twin study reveals genetic and environmental factors in multiple sclerosis
Time of Update: 2022-03-04
Researchers from the University of Zurich and other institutions have recently studied the peripheral immune signature of multiple pairs of identical twins to dissect the influence of genetic susceptibility and environmental factors .
-
The Second Qinghai-Tibet Plateau Expedition: New Genus and Species of Lichens Discovered
Time of Update: 2022-03-03
8;font-family:;font-size:12pt;}</> The Qinghai- Tibet Plateau is the third pole of the world, with an average altitude of more than 4,000 meters.
Based on multi-gene phylogenetic analysis , combined with morphological , anatomical and chemical evidences , this study redefines the concept of Immersaria , and establishes a new genus of the family Lecammeria : Lecammeria CM Xie, Lu L.
-
[Research News] The team of Professor Li Zifu and Professor Yang Xiangliang from the School of Life Sciences of Huazhong University of Science and Technology proposed a "precise and traceless" linker strategy to build efficient...
Time of Update: 2022-03-03
Based on the above background, in this study, five different linker-conjugated doxorubicin (DOX) dimers were designed and synthesized: DOX2-CC linked with stable fatty chain, DOX2-SS (SH ), GSH-responsive and DOX2-SS with original drug release, H2O2-responsive and original drug-released DOX2-Bor, and acid-responsive and original drug-released DOX2-DMA, and were observed in mouse triple-negative breast cancer in situ tumors and Two different tumor-bearing mouse models of hepatocellular carcinoma were compared for their antitumor efficacy .
-
Chinese scholars and overseas collaborators have made progress in magnetic reconnection research
Time of Update: 2022-03-03
High-resolution observations and numerical simulations of the magnetic reconnection process from the New Vacuum Telescope (NVST) and the Solar Dynamics Observatory (SDO) reveal the 3D structure and evolution of magnetic islands within the current sheet for fast magnetic reconnection in solar flares Funded by the National Natural Science Foundation of China (Grant Nos.
-
30 minutes to remove cancer cells!
Time of Update: 2022-03-03
com/amphtml/20220125A0369G00[3] China's first anti-cancer boron drug has completed the pilot test and is expected to be used in clinical practice in 2023https://baijiahao.
com/s?id=1718634397449191617&wfr=spider&for=pc[5] China's first anti-cancer boron drug has completed the pilot test, and can cure a variety of specific cancers in as fast as 30 minutes!https://page.
-
Xu Shuhua's team completed the de novo assembly of the Tujia uniparental gene sequences and demonstrated the necessity and application value of the construction of an ethnic group-specific reference genome
Time of Update: 2022-03-03
<> </> On February 17 , 2022 , the international academic journal Cell Systems published online the research results of Professor Xu Shuhua's team from the School of Life Sciences, Fudan University "
-
ORR of some patients reaches 100% Rongchang Biotech announces the latest research data of ADC velicitumumab
Time of Update: 2022-03-03
On February 17, during the 2022 American Society of Clinical Oncology Symposium on Genitourinary Oncology (ASCO-GU), Rongchang Biologics announced its HER2-targeted antibody-drug conjugate (ADC) vedicitumab combination therapy for the treatment of topical Recent clinical advances in advanced or metastatic urothelial carcinoma .
-
Nature's new discovery: This model animal is smarter than we know
Time of Update: 2022-03-03
"This study shows that Drosophila is not only capable of this advanced form of tracking conditioning, but that it learns as easily as mammals and humans are distracted, and that the neural activity underlying these attentional and working memory processes in Drosophila is similar to that in Drosophila.
-
eLife: A new approach to treating diabetes complications
Time of Update: 2022-03-03
"In our study, we wanted to find out whether the overproduction of cellular ROS in diabetes is due to an impaired response to hypoxia due to inhibition of HIF-1 by high blood glucose levels .
-
Embryonic development and cancer cell growth
Time of Update: 2022-03-03
"In this study, we observed that lung cancer cells, when cultured in human embryonic lung mesenchymal conditioned medium, lost their malignant phenotype, their morphology was altered, and their proliferation was suppressed both in vivo and in vitro .
-
Nature sub-journal reminds you: kitchen sponges are a gathering place for microorganisms
Time of Update: 2022-03-03
In a series of experiments, the scientists showed how different microbial species affect each other's population dynamics, depending on factors such as complexity and size of their structural environment .
-
South China Botanical Garden "a rapid propagation method of dancing ginger tissue culture" won the invention patent
Time of Update: 2022-03-03
The invention technology is simple and affordable, practical and high in application value .
The implementation of the invention only requires simple plant tissue culture equipment .
-
Pinpointing gene targets holds promise for treating many types of blindness
Time of Update: 2022-03-03
Laura Finnegan, lead author of the paper and PhD student at Trinity College, said:"In response to injury, SARM1 is involved in a process that causes the degeneration of specialized cells and their axons in the eye .
-
Cell's unexpected new discovery: HIV is not what we think it is
Time of Update: 2022-03-03
"All of these features increase the dynamic variability that the HIV spike protein presents to the immune system," said Lee, who also leads a University of Washington lab that studies virus structure and dynamics .